Background: Malignant hyperthermia susceptibility (MHS) is diagnosed by an invasive in vitro caffeine-halothane contracture test (CHCT) carried out on biopsied skeletal muscle tissue. We are presenting a novel blood test approach for malignant hyperthermia testing in a swine model. Our main aim was to determine whether adenosine production from lymphocytes after 4-chloro-m-cresol (4CmC) stimulation distinguishes homozygous swine carrying the Arg615Cys mutation in the ryanodine receptor type 1 (RyR1) gene (MHS swine) from normal swine. Methods: Lymphocytes were isolated from arterial blood (40 ml) obtained from MHS (n ϭ 7) and normal (n ϭ 7) swine. Cells were suspended in Hank's balanced salt solution and treated with 4CmC (0 -10 mM) at 37°C in the presence of adenosine deaminase inhibitor. After termination and purification of samples, aliquots (50 l) were assayed for adenosine content using high performance liquid chromatography. Results: Baseline adenosine levels before stimulating lymphocytes with 4CmC were 0.025 Ϯ 0.004 and 0.041 Ϯ 0.006 M (mean Ϯ SEM) in lymphocytes from normal and MHS swine, respectively (P ϭ 0.125). Maximum responses were achieved at 1 mM 4CmC for both cell-line groups. Adenosine levels after stimulation with 4CmC (1 mM) were 0.185 Ϯ 0.009 and 0.397 Ϯ 0.038 M in lymphocytes from normal and MHS swine, respectively (P ϭ 0.0035). There was no overlap between adenosine levels in stimulated lymphocytes from MHS and normal swine. Conclusion: 4CmC stimulation of porcine lymphocytes induces increased adenosine formation in MHS cells relative to those from normal swine; evaluation of adenosine formation in response to RyR1 agonists in human lymphocytes is needed.
and associated risks, it is estimated that only approximately 10% of eligible patients undergo CHCT (projected from referrals to the database of the North America Malignant Hyperthermia Hotline). Thus, a functional, minimally invasive, safe, relatively economical, and simple MH diagnostic test is desirable.
Several alternative MH tests have been considered in the literature as being less or minimally invasive. The most extensively investigated approach is molecular testing of the ryanodine receptor type 1 (RyR1) gene. [7] [8] [9] [10] [11] However, because the total number of mutations that could potentially alter or affect ryanodine receptor (RyR) function is not yet known, genetic screening has not been, and likely will not soon be, definitive enough to serve as the sole method for diagnosing MH. Functional MH tests using microdialysis, [12] [13] [14] immortalized B cells-Ca 2ϩ assay, 15, 16 and nuclear magnetic resonance spectroscopy 17 are either modestly invasive (microdialysis) or too technically involved and time consuming to be practical for use in MH diagnostic testing.
In the present study, we examine a novel blood test for utility in MH diagnosis using the well-characterized porcine MH model. Our approach isolates and compares lymphocytes (B ϩ T cells) from swine carrying a single MH mutation, Arg615Cys (referred to as "MHS swine" throughout), with lymphocytes from normal swine to determine whether significant differences in adenosine levels could be measured to distinguish the two from one another. 4-Chloro-m-cresol (4CmC), a chlorinated phenol that mimics the effects of caffeine and halothane by inducing release of sarcoplasmic reticulum (SR) Ca 2ϩ in skeletal muscles, 18 as well as in isolated SR vesicles 19 , was used to stimulate lymphocytes.
The endoplasmic reticulum/SR has two families of intracellular ion channels capable of releasing Ca 2ϩ : the inositol 1,4,5-trisphosphate (IP 3 ) receptor (IP 3 R) and the RyRs. IP 3 R agonists acting through G-protein-linked or tyrosine kinase-linked receptors stimulate phospholipase C to generate the second messenger IP 3 , which then diffuses into the cytoplasm to release stored Ca 2ϩ by binding to IP 3 R. 20, 21 IP 3 R can be activated by adenophostin A and inhibited by xestospongin C (XeC). 22 RyRs are found in muscle cells, neurons, and other cell types. [21] [22] [23] RyR-induced Ca 2ϩ release is activated by caffeine and 4CmC 19 but is inhibited by dantrolene/azumolene. 24 A correlation between cell Ca 2ϩ release leading to increased Ca 2ϩ ATPase-dependent Ca 2ϩ pumping and subsequent adenosine formation in lymphocytes has not been reported. However, in skeletal muscle, RyR1 is coupled to the dihydropyridine receptor. The dihydropyridine receptor is the voltage-sensitive L-type Ca 2ϩ channel. Mitochondria (the site of oxidative phosphorylation of adenosine 5Ј-diphosphate [ADP]) and glycolysis (the cytoplasmic site of substrate-level phosphorylation of ADP) synthesize adenosine 5Ј-triphosphate (ATP), which powers the ATP-dependent Ca 2ϩ pumps on the SR/endoplasmic reticulum and the sarcolemma. Intracellular Ca 2ϩ accumulation due to the activation and subsequent nonclosure/delay-closure of the RyR1 Ca 2ϩ channel triggers this ATPase-dependent Ca 2ϩ pumping, generating ADP and adenosine 5Ј-monophosphate (via adenylate kinase), leading to increased adenosine formation. [25] [26] [27] We demonstrate that (1) adenosine formation by 4CmCstimulated lymphocytes can be used to assess increased adenosine ATP turnover and catabolism resulting in increased adenosine formation; (2) defined mutation in RyR1 that leads to abnormal agonist-induced Ca 2ϩ release in skeletal muscle also leads to increase adenosine formation by lymphocytes; and (3) 4CmC-induced adenosine production is substantially greater in lymphocytes from MHS swine compared with normal swine. We attempted to identify Ca 2ϩ pools that could possibly contribute to measured 4CmCinduced adenosine formation in lymphocytes from normal swine by using specific blockers of IP 3 R, mitochondrial oxidative phosphorylation, and SR Ca 2ϩ release channels. We also considered extracellular Ca 2ϩ as a possible effector of intracellular Ca 2ϩ changes, thus potentially contributing to increased adenosine formation.
Materials and Methods
Experiments were designed to (1) examine the hypothesis that a defined mutation in the RyR1 gene of MHS swine that leads to abnormal agonist-induced Ca 2ϩ release in skeletal muscle will also lead to adenosine release in lymphocytes; (2) determine whether 4CmC stimulation of lymphocytes and adenosine production distinguishes between MHS and normal swine, and (3) delineate the possible effects of IP 3 R, mitochondrial uncoupling, external Ca 2ϩ , and the SR Ca 2ϩ release channels (RyR1) on the observed adenosine formation.
Animal Model
With approval of the Uniformed Services University of the Health Sciences (Bethesda, Maryland) institutional animal care and use committee, seven normal pigs (not MH-sensitive; Archer Farm, Darlington, MD) and seven homozygous MHS swine (Boyle Farms, Moorhead, IA) carrying an Arg615Cys mutation were sedated with ketamine (8 -10 mg/kg intramuscular injection). An ear vein was cannulated for inducing and maintaining anesthesia with propofol (0.2-0.4 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ). An endotracheal tube was inserted and ventilation was maintained with an end-tidal carbon dioxide of 40 Ϯ 5 mmHg. A rectal thermometer probe was placed to monitor and maintain core body temperature at 38.5°C. A 20-gauge cannula was inserted percutaneously into the superficial femoral artery. Blood pressure and heart rate were monitored continuously. Efforts were made to match the two experimental animal groups in regard to factors such as sex, age, or weight. After cardiovascular and respiratory indices stabilized, an arterial blood sample (40 ml) was withdrawn using a heparinized 60-ml syringe. After blood sampling, a skeletal muscle biopsy (vastus lateralis) for CHCT was performed as described previously. 3 Swine were then administered inhaled halothane (2%) for the induction of an MHS clinical episode.
Isolation of Lymphocytes from Whole Blood
Lymphocytes (B ϩ T cells) were isolated from whole blood by the Ficoll-Hypaque density gradient centrifugation technique. 28 Isolated lymphocyte cells were dispensed into 3-volume normal Hank's balanced salt solution (HBSS) and centrifuged (10 min at 1,000 revolutions per minute). The pellet was resuspended in HBSS to lyse contaminating erythrocytes and spun; this step was repeated once more. No further purification was attempted to maintain simplicity of the protocol for potential applicability in a possible MH diagnostic test in routine clinical practice. Lymphocytes were then cultured in RPMI-1640 media supplemented with 10% inactivated fetal bovine serum plus 100 units/ml penicillin and 2 mM glutamine. Cell cultures were incubated at 37°C in a humidified chamber with 5% CO 2 . All experiments were completed within 4 days after isolation of lymphocytes from whole blood samples.
Nucleosides Assay Protocol
Lymphocytes (1-2 ϫ 10 6 cells/test; cell counting was performed using hemacytometer) were suspended in HBSS with or without Ca 2ϩ /Mg 2ϩ as indicated for each experiment plus 0.1% endotoxin-free bovine serum albumin. Experiments were carried out in the presence of adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)-adenine-HCl (EHNA; 0.1 mM) to prevent deamination of adenosine to inosine 29 and incubated at 37°C for 10 min followed by treatment with different 4CmC concentrations (0.2-10 mM) and then incubated at 37°C for an additional 45 min. Final volume of the test tubes mixture were adjusted to 0.2 ml using HBSS buffer. Termination of adenosine metabolism and purification of samples were accomplished by addition of ice cold 0.1 ml 12% perchloric acid followed by centrifugation at 7,000 revolutions per minute for 10 min. Aliquots of supernatant (50 l) were assayed for adenosine and inosine content using the high performance liquid chromatography technique detailed below. The protocols used to study the effects of external Ca 2ϩ /Mg 2ϩ , SR Ca 2ϩ release blocker azumolene, inhibitor of IP 3 R xestospongin C (XeC), and mitochondria uncoupler carbonyl cyanide 4-(trifluoromethoxy) phenylhydrozone (FCCP), as well as the effect of EHNA, were the same as those given in the nucleoside assay protocol. Further details and specific conditions for each experiment are presented in the result section and figure legends.
High-Performance Liquid Chromatography Analysis
A chromatography protocol was developed using a high-performance liquid chromatography system (Waters Separations module, model 2695; Waters Co., Milford, MA) consisted of a Waters Symmetry C 18 column (4.6 ϫ 250 mm) and mobile phase of 94% KH 2 PO 4 (50 mM, pH 4.6) containing 1-heptanesulfonic acid (0.5 mM) and 6% acetonitrile. Flow rate was set at 1 ml/min. Under these conditions, retention times for inosine and adenosine were 3.6 and 6.6 min, respectively. Peak width of inosine and adenosine were 18 and 36 s, respectively. Eluted nucleosides were detected by their absorbance at ϭ 254 nm using Waters photodiode array detector (model 996). Sample adenosine and inosine concentrations were interpolated from a calibrated standard curve of concentrations versus peak area.
Statistics
Sample nucleoside concentrations were normalized to represent per 10 6 cells and presented as mean Ϯ SEM. SigmaPlot (version 10) and SigmaStat (version 3.5) software (Systat Software, Inc., Richmond, CA) were used to plot graphs and perform statistics, respectively. Pairwise comparisons using two-way analysis of variance with Bonferroni correction (␣ set to 0.05) were applied to test for statistical differences between multiple treatment groups. In addition, two-tailed t tests were done comparing two treatments of interest, and exact P values are presented in the text; P less than 0.05 indicated statistical significance.
Reagents
HBSS containing Ca 2ϩ /Mg 2ϩ (0.4 mM Ca 2ϩ and 0.5 mM Mg 2ϩ , referred to as normal HBSS) and Ca 2ϩ /Mg 2ϩ -free HBSS were from Invitrogen/GIBCO (Carlsbad, CA). The adenosine deaminase inhibitor EHNA (Sigma-Aldrich, St. Louis, MO) was dissolved in either normal HBSS or Ca 2ϩ / Mg 2ϩ -free HBSS (Sigma-Aldrich), depending on the protocol used, and stored at Ϫ20°C. KH 2 PO 4 , 1-heptanesulfonic acid, bovine serum albumin, adenosine, inosine, and other ordinary laboratory chemicals were from Sigma-Aldrich. RPMI-1640 culture media, fetal bovine serum, and penicillin were from Quality Biologic Inc. (Gaithersburg, MD). 4CmC (Sigma-Aldrich) was prepared daily in distilled water. Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP; Sigma-Aldrich) and XeC (Calbiochem, San Diego, CA) were dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich) and stored at Ϫ20°C. Azumolene was dissolved in DMSO and stored at Ϫ20°C.
Results
Although seven lymphocyte cell lines in each group of MHS and normal swine were examined, the numbers of cell lines in each protocol were variable due to limited availability of cells. Lymphocytes from MHS and normal swine were used to examine the effects of adenosine deaminase inhibitor EHNA on adenosine formation and on 4CmC dose-response experiments. Due to limited availability of the porcine MHS lymphocytes, only lymphocytes from normal swine were used to study the effects of external Ca 2ϩ , azumolene, XeC, and uncoupler FCCP on adenosine formation. In preliminary tests, we observed that adenosine formation in response to 4CmC was a function of the length of the cell culturing period. We found that after culturing cells for 10 days, more than 90% of the 4CmC effectiveness on lymphocytes was abolished in terms of adenosine formation (data not shown). Figure 1 shows 4CmC (1 mM)-induced adenosine/inosine formation in the presence and absence of 0.1 mM EHNA.
Effect of Adenosine Deaminase Inhibitor on Adenosine/ Inosine Levels
The lack or weak formation of adenosine response to 4CmC stimulation was due to immediate deamination of adenosine to inosine by the endogenous enzyme adenosine deaminase. This was confirmed when lymphocyte cells were incubated with various concentrations (0 -1,000 M) of EHNA. The results demonstrated that at EHNA concentrations of 20 M or higher, inosine formation decreased and adenosine concentration increased to plateau level (n ϭ 3, EHNA doseresponse data not shown). The observed differences in the molar concentrations of inosine and adenosine in figure 1 were likely due to degradation of inosine to hypoxanthine by endogenous purine nucleoside phosphorylase and, at least in part, also due to the differences in the molar absorption coefficient () of inosine compared with adenosine (the measuring wavelength was ϭ 254 nm; adenosine, max ϭ 258 nm, ϭ 15,100; inosine, max ϭ 248 nm, ϭ 12,200 [Merck Index]).
Effect of External Ca 2؉ /Mg 2؉ on 4CmC-induced Adenosine Formation
There were no differences between the basal resting adenosine levels of lymphocytes from normal swine (n ϭ 6) incubated in normal Ca 2ϩ /Mg 2ϩ -containing HBSS and Ca 2ϩ / Mg 2ϩ -free HBSS (0.015 Ϯ 0.003 and 0.013 Ϯ 0.003 M, P ϭ 0.7, respectively). However, using 1 mM 4CmC to induce adenosine in normal HBSS versus Ca 2ϩ /Mg 2ϩ -free HBSS, we measured 0.217 Ϯ 0.015 versus 0.163 Ϯ 0.017 M, P ϭ 0.037, respectively. This reflected a 24.9 Ϯ 5.1% increase in adenosine formation in the presence of normal levels of extracellular Ca 2ϩ . At 2 mM 4CmC, the difference increased to 0.189 Ϯ 0.015 in the presence of extracellular 
Effect of Azumolene
Effect of the membrane-permeable SR Ca 2ϩ release blocker azumolene was examined in 4CmC-treated cells. Azumolene is a more soluble SR Ca 2ϩ release blocker than the clinically used dantrolene. 24 Lymphocytes in the presence of EHNA were treated with DMSO (final DMSO concentration, 10% v/v) with and without different concentrations of azumolene (0 -1,000 M) and incubated at 37°C for 10 min followed by treatment with 1 mM 4CmC. As shown in figure 5 , azu- molene in concentrations up to 1 mM only marginally inhibited 4CmC-induced adenosine formation. Nonlinear curve fitting of these data suggested an apparent Ki value near 5 mM azumolene (data not shown). In an attempt to increase permeability of azumolene across the plasma membrane, we tested 30% (v/v) DMSO (n ϭ 3) as a vehicle. Results suggested that 30% DMSO concentration was toxic to the cells, causing significant decrease in the 4CmC-induced adenosine (data not shown).
Effect of XeC
XeC is a potent and selective inhibitor of IP 3 R coupled to a special intracellular pool of Ca 2 . 20 -22,29 -31 To determine whether IP 3 R contributed to the observed 4CmC-induced adenosine formation, normal lymphocyte cells in suspension in Ca 2ϩ /Mg 2ϩ -free HBSS were treated with DMSO (final concentration, 10% v/v) with and without XeC (1 and 10 M). This concentration range of XeC has been reported to be an effective physiologic concentration in various cell types. 20 -22 Figure 6 summarizes the observed effects of XeC on 4CmC-induced adenosine. XeC (1 and 10 M) alone did not affect the basal adenosine levels (data not shown). Likewise, 1 M XeC did not affect 4CmC-induced adenosine. However 10 M XeC significantly decreased 4CmC-induced adenosine by 27% (P ϭ 0.002), suggesting that IP 3 R-coupled intracellular Ca 2ϩ stored in porcine lymphocytes, may contribute, in part, to 4CmC-observed adenosine formation (see fig. 3 ).
Effect of Uncoupler FCCP on 4CmC-induced Adenosine in Lymphocyte Cells
Using normal lymphocytes in the absence of extracellular Ca 2ϩ /Mg 2ϩ , FCCP (2 and 20 M) alone increased basal adenosine levels several-fold (up to 350%) to 0.1-0.12 M ( fig. 7 , bars A, P Ͻ 0.008), which is consistent with ATP catabolism due to mitochondrial uncoupling. Micromolar concentrations of FCCP are known to effectively uncouple mitochondrial respiration from oxidative phosphorylation of . Sample adenosine concentrations were normalized to reflect value per 10 6 cells. Cells (1-2 ϫ 10 6 ) in suspension in normal Hank's balanced salt solution containing adenosine deaminase inhibitor (erythro-9(2-hydroxy-3-nonyl) adenine, 0.1 mM) were incubated at 37°C for 10 min followed by treatment for additional 30 min with different 4CmC concentrations as indicated. *4CmC-induced adenosine levels in presence of 0.5, 1, 2, or 5 mM are significantly higher in the MHS group than in the normal control group; P values were 0.0035, 0.0035, 0.0017, and 0.0008, respectively. . Sample adenosine concentrations were normalized to reflect value per 10 6 cells. Cells (1-2 ϫ 10 6 ) in suspension in normal Hank's balanced salt solution containing adenosine deaminase inhibitor (erythro-9(2-hydroxy-3-nonyl) adenine, 0.1 mM) were incubated at 37°C for 10 min followed by treatment for additional 30 min with different 4CmC concentrations as indicated. Baseline adenosine levels before 4CmC treatments were not significant different between lymphocyte cells from MHS versus normal swine. adenosine in many cell types. [32] [33] [34] Combining FCCP with subsequent 4CmC (2 mM) did not further increase adenosine formation ( fig. 7, bars B) , most likely reflecting Ca 2ϩ depletion of the SR due to previous FCCP treatment.
CHCT Results
Halothane (3%)-induced contractures in muscle strips from MHS and normal swine were 19.2 Ϯ 3.1 mN (range, 11.2-33.1 mN) and 1.2 Ϯ 1.0 mN (range, 0 -1.8 mN), respectively. Caffeine (2 mM)-induced contractures in muscle strips from MHS and normal swine were 10.2 Ϯ 1.8 mN (range, 4.7-17.1 mN) and 0.4 Ϯ 0. 2 mN (range, 0 -1 mN) , respectively. All MHS swine developed MH episodes in response to 2% halothane, whereas the normal swine did not.
Discussion
The major findings of this pilot study may be summarized as follows: (1) 4CmC treatment of lymphocytes from MHS and normal swine produces cellular energetic stress that is indexed by increased adenosine formation; (2) 4CmC-induced adenosine formation in lymphocytes distinguishes between MHS and normal swine because there is no overlap between groups; (3) extracellular Ca 2ϩ significantly influences 4CmC-induced adenosine formation in swine lymphocytes, indicating increased transmembrane Ca 2ϩ fluxes during cellular de-energization; (4) azumolene, a SR Ca 2ϩ release blocker, in concentrations up to 1 mM, did not significantly decrease 4CmC-induced adenosine in lymphocytes from normal swine; (5) IP 3 R-linked Ca 2ϩ release may also contribute to 4CmC-induced adenosine; (6) uncoupled mitochondria result in near-maximal adenosine formation due to ATP depletion and possibly mitochondrial matrix Ca 2ϩ depletion; and (7) evaluation in human lymphocytes is needed to clarify whether the use of adenosine as an index of cellular Ca 2ϩ stress and pumping in lymphocytes has clinical potential as an MH diagnostic blood test.
In this study, only a relatively small number of MHS animals were examined; nevertheless, the data showed that there was no overlap between 4CmC-induced adenosine values in the MHS group versus the normal group. However, until additional experiments are performed, it cannot be stated with certainty that by increasing number of animals in each group, overlap between 4CmC-induced adenosine will not occur. The overlap in adenosine levels may be expected to be greater in humans because there are more mutations found to be causal for MH than in the purebred swine.
There are similarities and differences between 4CmCinduced Ca 2ϩ release via the RyR1-sensitive stores in Epstein-Barr virus immortalized human B cells 15, 16 and the present finding on adenosine formation by 4CmC stimulated swine lymphocytes. 4CmC and caffeine-induced Ca 2ϩ release are partially blocked by azumolene, a more watersoluble blocker of SR Ca 2ϩ release than sodium dantrolene. Using the Dakiki cell line, McKinney et al. 34 showed that 0.1 and 0.4 mM azumolene inhibited 4CmC-induced Ca 2ϩ release by 23 and 50%, respectively. However, in the present study, 1 mM azumolene, the highest concentration applied, inhibited 4CmC-induced adenosine formation in normal swine lymphocytes only by 14%, and this effect was not statistically significant. An explanation for this discrepancy is . In brief, one set of lymphocytes was suspended in Ca 2ϩ /Mg 2ϩ -free Hank's balanced salt solution plus adenosine deaminase inhibitor ((erythro-9(2-hydroxy-3-nonyl) adenine, 1 mM), with and without FCCP at 37°C for 10 min (bars A). In the second set of samples, cells were treated the same as in the first set; then, after the 10-min incubation period, lymphocytes were treated with 2 mM 4CmC and incubated for an additional 30 min at 37°C (bars B). Adenosine data were normalized to represent value per 10 6 cells. *FCCP (2 and 20 M) alone significantly increased basal adenosine levels. #In the absence of FCCP, 4CmC-induced adenosine formation was 5.8-fold higher compared with basal adenosine level. not immediately obvious but could possibly be related to different experimental conditions in our nonimmortalized swine lymphocytes compared with the Epstein-Barr virus immortalized Dakiki B cell line protocols, 34 as a result of differences between cell lines from two different species and the differences in 4CmC-induced Ca 2ϩ and adenosine release mechanism.
The data suggested that removal of external Ca 2ϩ /Mg 2ϩ eliminated net Ca 2ϩ influx and/or enabled increased net Ca 2ϩ efflux across the plasma membrane in presence of 4CmC, and that such transmembrane Ca 2ϩ fluxes contributed significantly to the overall intracellular Ca 2ϩ dysregulation during cell activation by 4CmC. Thus, the adenosine formation observed under the Ca 2ϩ -free HBSS conditions likely reflected the energetic stress and associated ADP and adenosine 5Ј-monophosphate formation triggered by increased Ca 2ϩ ATPase activity in response to the Ca 2ϩ release from intracellular stores. [25] [26] [27] Our data show that the effect of physiologic millimolar extracellular Ca 2ϩ on 4CmC-induced adenosine formation was substantial, accounting for 24.9 Ϯ 5.1 or 41 Ϯ 2.5% of total adenosine production in the presence of 1 or 2 mM 4CmC, respectively, under our experimental conditions.
In addition to RyR1-linked Ca 2ϩ stores, there are other physiologically important intracellular pools of Ca 2ϩ , mainly the IP 3 -sensitive stores 20, 21 and the mitochondrial matrix Ca 2ϩ pool. [32] [33] 35 According to our findings, it seems not unlikely that the IP 3 -sensitive stores, especially, could contribute to cellular Ca 2ϩ dysregulation (and adenosine formation) secondary to maximal SR Ca 2ϩ release channel agonism caused by 4CmC in swine lymphocytes ( fig. 3 ). This notion is supported by the following facts and observations: XeC, a potent and selective inhibitor of the IP 3 R in several cell lines, 22,31 had a concentration-dependent inhibitory effect on 4CmC-induced adenosine in normal swine lymphocytes ( fig.  6 ). At 1 M, XeC had no measurable effect on 4CmC-induced adenosine formation, which compares well with the lack of 1 M XeC effects on Ca 2ϩ release in the Dakiki cell line. 34 However, at 10 M, XeC inhibited 4CmC-induced adenosine significantly by 27%, providing pharmacological evidence that IP 3 R-mediated Ca 2ϩ release might indirectly contribute (via additional Ca 2ϩ release secondary to 4CmC induced Ca 2ϩ release) to 4CmC-induced adenosine formation in swine lymphocytes under our conditions.
Mitochondria are the sites of oxidative phosphorylation of ADP and the generation of reactive superoxide radicals; the mitochondrial matrix is a subcellular calcium store and therefore could contribute to cytosolic Ca 2ϩ under conditions of deenergization. 33, 35 In addition, it has been reported that mitochondria express RyRs on their outer membrane, 36 but this conclusion could not be confirmed by other investigators. [37] [38] FCCP is an uncoupler of oxidative phosphorylation causing severe depolarization of the inner mitochondrial membrane, which is associated with a depletion of mitochondrial matrix Ca 2ϩ . 36 Application of FCCP alone on swine lymphocyte cells substantially increased basal level of adenosine in Ca 2ϩ -free incubation media. Also this effect of FCCP compares well with the previously reported FCCPinduced Ca 2ϩ accumulation in human Epstein-Barr virus immortalized B cells. 34 Taken together, these findings demonstrate increased ATP catabolism as a result of impaired cellular calcium control; they also suggest that adenosine could be a readily measurable marker for increased susceptibility to the hypermetabolic state of malignant hyperthermia and, in addition, they are consistent with 31 P-NMR data by Olgin et al. 17 in patients.
In conclusion, this article presents a novel and relatively simple protocol that uses lymphocytes and employs adenosine production as a marker to distinguish between normal and MHS in a well-described swine model. The MH-specificity of the protocol is provided by the use of RyR1 agonist 4CmC. The Ca 2ϩ contributing to adenosine responses could come from several sources, including the SR Ca 2ϩ release channels, the IP 3 R pool, and extracellular as well as mitochondrial Ca 2ϩ . This protocol approach may be applicable in MH diagnostic and screening tests in humans, but for validation, further studies are needed.
